Light therapy shows promise for tight skin diseases
NCT ID NCT04922736
First seen Jan 25, 2026 · Last updated May 17, 2026 · Updated 23 times
Summary
This study looks at whether 30 sessions of UVA-1 light therapy can improve how people with scleroderma, morphea, or skin-related graft-versus-host disease feel and function in daily life. About 30 adults will receive the treatment and report their symptoms using questionnaires. The goal is to see if this therapy eases the burden of these hard-to-measure skin conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT VS HOST DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Utah Dermatology
Murray, Utah, 84132, United States
Conditions
Explore the condition pages connected to this study.